GlassScriptPhysician profile
Todd W Mautner
NPI 1831637321
$8,875.92
in general payments reported to CMS, 2019-2025
15 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,113 · 2022: $5,320 · 2023: $986 · 2024: $336 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,442.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,442.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $6,856.28 | 2021-2025 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System |
| Saluda Medical Americas, INC. | $513.95 | 2022-2023 | Evoke Scs |
| Medtronic, INC. | $285.78 | 2021-2023 | Intellis Adaptivestim |
| Nevro Corp. | $264.19 | 2022 | |
| Spr Therapeutics, INC | $241.04 | 2021-2023 | Sprint Pns System |
| Mml US, INC. | $148.53 | 2022 | |
| Abbott Laboratories | $145.39 | 2022 | |
| Relievant Medsystems, INC. | $118.20 | 2021 | |
| Nalu Medical, INC. | $111.01 | 2021 | |
| Merck Sharp & Dohme LLC | $48.25 | 2023-2025 | Bridion |
| Grt US Holding, INC. | $46.52 | 2022 | |
| Curonix LLC | $31.33 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Spinal Simplicity, LLC | $30.95 | 2024 | Ha Minuteman G3-R |
| Averitas Pharma INC. | $19.97 | 2023 | Qutenza |
| Painteq LLC | $14.53 | 2023 | Painteq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Mautner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.